trans-4-((6-Chloropyrimidin-4-yl)amino)cyclohexanol
97%
science Other reagents with same CAS 1261230-58-3
blur_circular Chemical Specifications
description Product Description
Used as a key intermediate in the synthesis of Janus kinase (JAK) inhibitors, particularly in the development of pharmaceuticals targeting inflammatory and autoimmune diseases such as rheumatoid arthritis and psoriasis. Its structure enables selective modulation of JAK enzyme activity, contributing to reduced inflammation and immune response. Widely utilized in medicinal chemistry for optimizing potency and selectivity in drug candidates.
shopping_cart Available Sizes & Pricing
Cart
No products